Type of Cancer
Multiple Myeloma
Phase
Division (Location)
Study ID
NCT#
Brief Description
“CC#139511: A Phase Ib Study of SAR650984 (Anti-CD38 mAb) in Combination with Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.